The global incidence of breast cancer has been on the rise since the late 1970s. According to the statistics published by National Cancer Center and CDC of the Ministry of Health, the incidence of breast cancer comes in the first place in malignant tumors among women in tumor registration areas. The national breast cancer incidence among women (crude rate) amounts to 425,500/100,000, which has become a major public health and social issue nowadays.
With the benefits of intuitive results, stability, simple operation, rich sample sources, etc., fluorescent in situ hybridization(FISH), through detection of special locus, provides support in clinical typing for breast cancer patients and predicting prognosis. It is also used for medication guidance and providing important basis for individualized and precise treatment.
Product list
Code | Product | Locus | Pack size |
CT-PAC001-10-OG | ERBB2/CCP17 FISH Probe Kit | 17q12 17p11-q11 | 10 Assay/Kit |
CT-PAC101-10-OG | PTEN/CCP10 FISH Probe Kit | 10q23.31 10p11-q11 | 10 Assay/Kit |
CT-PAC169-10-OG | SEC63/MYC FISH Probe Kit | 6q21 8q24.21 | 10 Assay/Kit |
CT-PAC008-10-OG | TOP2A/CCP17 FISH Probe Kit | 17q21.2 17p11-q11 | 10 Assay/Kit |
CT-PAC073-10-OG | ZNF217/CCP20 FISH Probe Kit | 20q13.2 20p11-q11 | 10 Assay/Kit |
CT-PAC208-10-OG | MYC Break Apart FISH Probe Kit | 8q24.21 | 10 Assay/Kit |